Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 02 04:00PM ET
123.99
Dollar change
-0.69
Percentage change
-0.55
%
IndexNDX, S&P 500 P/E- EPS (ttm)-7.34 Insider Own0.50% Shs Outstand159.00M Perf Week2.43%
Market Cap19.70B Forward P/E50.70 EPS next Y2.45 Insider Trans0.89% Shs Float158.10M Perf Month-2.94%
Income-1161.00M PEG- EPS next Q0.04 Inst Own93.55% Short Float3.34% Perf Quarter-14.92%
Sales4.50B P/S4.37 EPS this Y2.08% Inst Trans2.72% Short Ratio3.27 Perf Half Y13.32%
Book/sh36.13 P/B3.43 EPS next Y178.58% ROA-10.38% Short Interest5.27M Perf Year-36.47%
Cash/sh6.63 P/C18.69 EPS next 5Y22.90% ROE-18.81% 52W Range89.00 - 213.91 Perf YTD-10.95%
Dividend Est.- P/FCF69.87 EPS past 5Y- ROI-14.66% 52W High-42.04% Beta1.24
Dividend TTM- Quick Ratio1.29 Sales past 5Y7.40% Gross Margin60.97% 52W Low39.31% ATR (14)4.63
Dividend Ex-Date- Current Ratio1.66 EPS Y/Y TTM73.83% Oper. Margin-1.62% RSI (14)46.94 Volatility3.27% 3.62%
Employees12010 Debt/Eq0.39 Sales Y/Y TTM-1.72% Profit Margin-25.78% Recom2.46 Target Price151.55
Option/ShortYes / Yes LT Debt/Eq0.38 EPS Q/Q-24.92% Payout- Rel Volume0.99 Prev Close124.68
Sales Surprise3.19% EPS Surprise652.69% Sales Q/Q3.60% EarningsMay 02 AMC Avg Volume1.61M Price123.99
SMA20-0.05% SMA50-5.02% SMA200-9.94% Trades Volume1,601,342 Change-0.55%
Date Action Analyst Rating Change Price Target Change
Jan-16-24Downgrade HSBC Securities Buy → Hold
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $144
Dec-18-23Upgrade Scotiabank Sector Perform → Sector Outperform $185
Dec-15-23Upgrade Bernstein Underperform → Mkt Perform
Dec-14-23Initiated Stephens Overweight $170
Dec-14-23Initiated Guggenheim Buy $155
Dec-13-23Initiated Wolfe Research Outperform $175
Dec-12-23Downgrade BofA Securities Neutral → Underperform $140 → $100
Dec-11-23Upgrade Citigroup Sell → Neutral $85 → $120
Nov-10-23Downgrade Canaccord Genuity Buy → Hold $210 → $120
Today 05:35PM
05:21PM
04:17PM
04:05PM
06:04AM
09:09PM Loading…
Apr-29-24 09:09PM
12:45PM
09:16AM
Apr-26-24 06:03AM
Apr-25-24 10:02AM
08:53AM
Apr-21-24 08:30AM
Apr-19-24 02:05PM
12:10PM
Apr-18-24 01:30PM
08:00AM Loading…
08:00AM
Apr-17-24 09:30AM
Apr-15-24 05:40AM
Apr-12-24 09:00AM
06:21AM
05:49AM
Apr-10-24 08:16AM
Apr-09-24 11:37PM
05:28PM
04:32PM
04:28PM
04:18PM
04:05PM
Apr-05-24 02:27PM
12:45PM
05:00PM Loading…
Apr-04-24 05:00PM
Apr-02-24 09:45AM
Mar-30-24 07:43PM
Mar-26-24 08:02AM
Mar-25-24 06:17AM
Mar-21-24 06:37PM
05:44AM
05:12AM
05:01AM
Mar-18-24 12:40PM
Mar-17-24 08:50AM
Mar-14-24 07:42PM
Mar-13-24 06:43AM
Mar-12-24 04:50PM
02:41PM
01:57PM
Mar-08-24 08:45AM
Mar-07-24 03:00PM
08:45AM
Mar-02-24 02:30PM
Feb-28-24 05:52AM
Feb-27-24 03:40AM
03:09AM
Feb-26-24 06:29PM
11:00AM
Feb-24-24 06:50AM
Feb-23-24 07:59AM
Feb-21-24 07:42PM
09:00AM
Feb-20-24 10:25AM
Feb-14-24 07:00PM
09:40AM
Feb-09-24 11:19AM
07:52AM
07:39AM
05:45AM
01:32AM
Feb-08-24 06:30PM
05:24PM
04:34PM
04:24PM
04:05PM
09:14AM
Feb-05-24 09:16AM
Feb-01-24 09:10PM
Jan-30-24 07:31AM
Jan-29-24 07:49PM
Jan-28-24 09:25AM
Jan-23-24 08:45PM
Jan-19-24 08:25AM
Jan-18-24 07:52AM
05:04AM
Jan-17-24 12:04PM
Jan-16-24 10:11AM
Jan-15-24 07:00AM
Jan-12-24 09:45AM
Jan-11-24 09:45AM
Jan-09-24 05:28PM
02:02PM
09:00AM
07:05AM
05:38AM
03:34AM
Jan-08-24 12:45PM
Jan-05-24 09:15AM
Jan-04-24 08:17PM
04:05PM
09:15AM
Dec-28-23 01:02PM
Dec-27-23 10:45AM
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thaysen JacobChief Executive OfficerFeb 22 '24Buy135.297,330991,67214,861Feb 26 08:57 AM
Hoyt Aimee LSVP, Chief People OfficerNov 07 '23Sale112.8431535,5458,314Nov 09 04:22 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerAug 22 '23Sale167.0450083,52045,524Aug 24 04:19 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerJul 24 '23Sale190.0850095,04046,022Jul 26 06:14 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerJun 22 '23Sale200.00500100,00046,522Jun 26 05:23 PM
EPSTEIN ROBERT SDirectorMay 25 '23Option Exercise71.097,600540,28414,764May 25 04:34 PM
Last Close
May 02 04:00PM ET
137.52
Dollar change
-1.17
Percentage change
-0.84
%
A Agilent Technologies Inc. daily Stock Chart
IndexS&P 500 P/E32.76 EPS (ttm)4.20 Insider Own0.41% Shs Outstand292.12M Perf Week0.84%
Market Cap40.30B Forward P/E22.53 EPS next Y6.11 Insider Trans-11.59% Shs Float291.84M Perf Month-4.32%
Income1.24B PEG4.07 EPS next Q1.19 Inst Own92.85% Short Float1.41% Perf Quarter3.36%
Sales6.74B P/S5.98 EPS this Y1.15% Inst Trans-3.29% Short Ratio2.60 Perf Half Y33.04%
Book/sh21.12 P/B6.51 EPS next Y10.95% ROA11.30% Short Interest4.12M Perf Year2.23%
Cash/sh5.96 P/C23.06 EPS next 5Y8.05% ROE20.95% 52W Range96.80 - 151.58 Perf YTD-1.09%
Dividend Est.0.94 (0.69%) P/FCF24.44 EPS past 5Y33.93% ROI13.95% 52W High-9.28% Beta1.09
Dividend TTM0.92 (0.67%) Quick Ratio2.04 Sales past 5Y7.00% Gross Margin54.54% 52W Low42.07% ATR (14)3.45
Dividend Ex-DateApr 01, 2024 Current Ratio2.68 EPS Y/Y TTM-5.40% Oper. Margin23.91% RSI (14)46.13 Volatility2.29% 2.39%
Employees18100 Debt/Eq0.44 Sales Y/Y TTM-2.81% Profit Margin18.35% Recom2.33 Target Price150.54
Option/ShortYes / Yes LT Debt/Eq0.43 EPS Q/Q-0.13% Payout21.48% Rel Volume0.72 Prev Close138.69
Sales Surprise4.45% EPS Surprise5.31% Sales Q/Q-5.58% EarningsApr 18 AMC Avg Volume1.58M Price137.52
SMA20-1.21% SMA50-2.89% SMA2008.17% Trades Volume1,146,811 Change-0.84%
Date Action Analyst Rating Change Price Target Change
Apr-05-24Upgrade Stifel Hold → Buy $145 → $163
Dec-13-23Initiated Wolfe Research Outperform $140
Dec-12-23Downgrade BofA Securities Buy → Neutral $130 → $133
Nov-17-23Downgrade UBS Buy → Neutral $163 → $125
Sep-28-23Initiated Bernstein Mkt Perform $123
Jul-31-23Downgrade Evercore ISI Outperform → In-line $126 → $124
May-24-23Reiterated Wells Fargo Overweight $170 → $160
May-24-23Reiterated TD Cowen Outperform $168 → $145
May-24-23Reiterated SVB Securities Outperform $170 → $145
May-24-23Reiterated Stifel Hold $153 → $135
Today 04:53PM
12:10PM
11:45AM
09:30AM
May-01-24 10:31AM
08:45AM Loading…
08:45AM
08:00AM
Apr-29-24 08:45AM
Apr-18-24 04:30PM
Apr-16-24 08:00AM
Apr-15-24 08:00AM
Apr-09-24 11:37PM
12:02PM
10:41AM
Apr-05-24 09:55AM
08:00AM Loading…
Apr-04-24 08:00AM
Apr-03-24 08:00AM
Apr-02-24 11:15AM
08:00AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-28-24 11:30AM
Mar-27-24 05:01PM
Mar-26-24 02:00AM
Mar-14-24 08:00AM
Mar-12-24 05:00PM
Mar-06-24 09:30AM
12:01AM
Mar-05-24 02:21PM
Mar-04-24 07:45PM
08:00AM Loading…
Feb-29-24 08:00AM
Feb-28-24 04:21PM
12:53PM
10:03AM
09:36AM
09:21AM
08:07AM
Feb-27-24 09:27PM
06:58PM
06:00PM
05:20PM
04:32PM
04:15PM
04:05PM
Feb-26-24 12:23PM
Feb-22-24 11:33AM
09:15AM
05:12AM
Feb-21-24 04:45PM
04:25PM
04:20PM
04:12PM
Feb-20-24 06:15PM
Feb-14-24 06:15PM
Feb-13-24 10:11AM
Feb-08-24 06:15PM
08:00AM
Feb-07-24 11:20AM
Feb-05-24 06:30AM
Feb-02-24 06:15PM
06:27AM
Jan-31-24 07:00AM
Jan-30-24 11:07AM
08:00AM
Jan-29-24 09:26AM
Jan-26-24 06:15PM
Jan-25-24 12:29PM
Jan-22-24 03:35PM
Jan-17-24 12:58PM
Jan-16-24 08:00AM
Jan-09-24 05:21AM
Jan-05-24 10:29AM
Dec-28-23 08:51PM
Dec-22-23 05:23AM
Dec-21-23 01:02AM
Dec-20-23 11:30AM
08:58AM
Dec-18-23 10:01AM
Dec-16-23 07:01AM
Dec-14-23 03:17PM
Dec-09-23 03:05AM
Dec-07-23 09:46AM
08:00AM
Dec-06-23 02:46AM
Dec-04-23 08:00AM
Nov-21-23 05:12PM
04:14PM
03:42PM
01:20PM
12:35PM
12:12PM
12:00PM
11:08AM
10:02AM
07:33AM
Nov-20-23 07:28PM
06:00PM
04:41PM
04:22PM
04:05PM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Binns PhilipSenior Vice PresidentMar 25 '24Sale147.542,827417,0969,997Mar 27 01:29 PM
McMullen Michael R.CEO and PresidentMar 08 '24Sale150.0052,2977,844,550253,909Mar 12 02:37 PM
Gonsalves RodneyV.P., Corporate ControllerMar 07 '24Sale149.004,828719,34821,329Mar 08 12:05 PM
FIELDS HEIDIDirectorMar 05 '24Sale144.341,658239,31654,976Mar 07 10:38 AM
Binns PhilipSenior Vice PresidentDec 27 '23Sale139.782,880402,56612,824Dec 28 01:46 PM
Gonsalves RodneyV.P., Corporate ControllerDec 18 '23Sale137.691,500206,53826,133Dec 19 02:34 PM
Ancher-Jensen HenrikSr Vice PresidentDec 15 '23Option Exercise111.3611,7031,303,235108,835Dec 19 02:33 PM
Ancher-Jensen HenrikSr Vice PresidentDec 15 '23Sale138.3626,3313,643,15782,504Dec 19 02:33 PM
McMullen Michael R.CEO and PresidentDec 13 '23Option Exercise42.122,751115,872308,957Dec 15 05:08 PM
McMullen Michael R.CEO and PresidentDec 13 '23Sale130.002,751357,630306,206Dec 15 05:08 PM
McMullen Michael R.CEO and PresidentDec 07 '23Option Exercise42.1262,4672,631,110368,673Dec 08 02:59 PM
McMullen Michael R.CEO and PresidentDec 07 '23Sale130.0062,4678,120,710306,206Dec 08 02:59 PM
Gonsalves RodneyV.P., Corporate ControllerSep 28 '23Buy111.09328824,222Sep 29 04:03 PM
Gonsalves RodneyV.P., Corporate ControllerAug 23 '23Sale118.783,500415,71624,219Aug 25 12:53 PM
McMullen Michael R.CEO and PresidentJul 27 '23Option Exercise42.1294439,761261,813Jul 31 03:03 PM
McMullen Michael R.CEO and PresidentJul 27 '23Sale130.00944122,720260,869Jul 31 03:03 PM